UBS AM’s Rocket Pharmaceuticals RCKT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $701K | Buy |
286,312
+101,620
| +55% | +$249K | ﹤0.01% | 2450 |
|
|
2025
Q1 | $1.23M | Buy |
184,692
+45,120
| +32% | +$301K | ﹤0.01% | 2220 |
|
|
2024
Q4 | $1.75M | Buy |
139,572
+19,939
| +17% | +$251K | ﹤0.01% | 2116 |
|
|
2024
Q3 | $2.21M | Buy |
119,633
+1,561
| +1% | +$28.8K | ﹤0.01% | 1986 |
|
|
2024
Q2 | $2.54M | Buy |
118,072
+52,282
| +79% | +$1.13M | ﹤0.01% | 1869 |
|
|
2024
Q1 | $1.77M | Sell |
65,790
-5,221
| -7% | -$141K | ﹤0.01% | 1745 |
|
|
2023
Q4 | $2.13M | Buy |
71,011
+20,841
| +42% | +$625K | ﹤0.01% | 1662 |
|
|
2023
Q3 | $1.03M | Buy |
50,170
+18,499
| +58% | +$379K | ﹤0.01% | 1946 |
|
|
2023
Q2 | $543K | Hold |
31,671
| – | – | ﹤0.01% | 2287 |
|
|
2023
Q1 | $543K | Sell |
31,671
-21,800
| -41% | -$373K | ﹤0.01% | 2287 |
|
|
2022
Q4 | $1.05M | Buy |
53,471
+14,333
| +37% | +$280K | ﹤0.01% | 1831 |
|
|
2022
Q3 | $625K | Hold |
39,138
| – | – | ﹤0.01% | 2241 |
|
|
2022
Q2 | $539K | Hold |
39,138
| – | – | ﹤0.01% | 2276 |
|
|
2022
Q1 | $621K | Hold |
39,138
| – | – | ﹤0.01% | 2377 |
|
|
2021
Q4 | $854K | Sell |
39,138
-8,342
| -18% | -$182K | ﹤0.01% | 2298 |
|
|
2021
Q3 | $1.42M | Sell |
47,480
-1,372
| -3% | -$41K | ﹤0.01% | 1991 |
|
|
2021
Q2 | $2.16M | Buy |
48,852
+11,512
| +31% | +$510K | ﹤0.01% | 1806 |
|
|
2021
Q1 | $1.66M | Buy |
37,340
+1,869
| +5% | +$82.9K | ﹤0.01% | 1835 |
|
|
2020
Q4 | $1.95M | Hold |
35,471
| – | – | ﹤0.01% | 1698 |
|
|
2020
Q3 | $811K | Buy |
35,471
+4,080
| +13% | +$93.3K | ﹤0.01% | 1925 |
|
|
2020
Q2 | $657K | Buy |
+31,391
| New | +$657K | ﹤0.01% | 1995 |
|
|
2020
Q1 | – | Sell |
-9,414
| Closed | -$214K | – | 2519 |
|
|
2019
Q4 | $214K | Buy |
+9,414
| New | +$214K | ﹤0.01% | 2462 |
|
|
2019
Q3 | – | Sell |
-12,438
| Closed | -$187K | – | 2898 |
|
|
2019
Q2 | $187K | Buy |
+12,438
| New | +$187K | ﹤0.01% | 2558 |
|